Salt induces oxidative stress in salt-sensitive (SS) animals and man. It is not known whether in SS subjects the low-sodium dietary approaches to stop hypertension (LS-DASH) reduces oxidative stress more than DASH, which is high in antioxidants. To assess the effects of DASH and LS-DASH on oxidative stress, 19 volunteers were studied after 3 weeks of a standardized usual low fruits and vegetables diet (ULFV), followed by 3 weeks on DASH (both diets B120 mmol Na þ per day), then 3 weeks on LS-DASH (60 mmol Na þ per day). SS was defined as systolic blood pressure X5 mm Hg lower on LS-DASH than DASH. In SS subjects (N ¼ 9), systolic blood pressure was lower on LS-DASH (111.0±2.0 mm Hg) than DASH (118.0±2.2, Po0.01) and ULFV (122.3±2.7, P ¼ 0.002). In salt-resistant (SR) volunteers (N ¼ 10), systolic blood pressure was lower on DASH (113.0 ± 1.6) than ULFV (119.0 ± 1.8, Po0.05) but not LS-DASH (115.7 ± 1.8). Urine F2-isoprostanes, a marker of oxidative stress, were lower in SS subjects on LS-DASH (1.69±0.24) than ULFV (3.09±0.50, Po0.05) and marginally lower than DASH (2.46±0.44, Po0.20). F2-isoprostanes were not different among the three diets in SR volunteers (2.18 ± 0.29, 2.06 ± 0.29, 2.27±0.53, respectively). Aortic augmentation index, a measure of vascular stiffness, was lower in SS subjects on LS-DASH than either DASH or ULFV, and lower on DASH than ULFV in SR volunteers. In SS but not SR subjects, LS-DASH is associated with lower values for F2-isoprostanes and the aortic augmentation index. The results suggest that LS-DASH decreases oxidative stress, improves vascular function and lowers blood pressure in SS but not SR volunteers.
Introduction
Several epidemiological and clinical studies demonstrated a clear relationship between salt intake and hypertension. 1 However, the blood pressure (BP) response to changes in dietary salt are heterogeneous among individuals. Several studies have classified humans as salt-sensitive (SS) or saltresistant (SR) based on BP responses to differences in sodium balance. 2, 3 Although the pathophysiological and genetic factors underlying salt sensitivity are increasingly well understood, the mechanisms are not yet fully elucidated.
The literature suggests that oxidative stress participates in the pathogenesis of hypertension. Studies in hypertensive patients have identified evidence for low antioxidant capacity 4 and increased oxidative stress. 5 In experimental models of SS hypertension, high salt intake increases markers of vascular and systemic oxidative stress. 2 Furthermore, highsalt diets impair vascular dilatation by decreasing nitric oxide in both SS animals and humans. 6, 7 Although several studies have linked increased oxidative stress to high salt intake in animals, [8] [9] [10] [11] the human data are more limited. In a study by Laffler et al., 12 acute (one-day) sodium loading and depletion using an established protocol produced corresponding increases and decreases, respectively, in plasma F2-isoprostanes in SS hypertensive subjects. In contrast, SR hypertensive subjects manifested an increase in plasma F2-ispoprostanes with salt depletion.
In a study of hypertensive patients by Sanchez et al., 13 non-modulators (SS) showed higher 24-h urine isoprostane values than modulators (SR) on both high-and low-sodium diets for 10 days each. Unlike modulators, the non-modulators also failed to increase urinary nitrate/nitrate and cyclic GMP on the high-salt diet as compared to low-salt diet. Thus, both the acute and intermediate-term studies of sodium loading and depletion suggest that markers of oxidative stress differ in SS and SR subjects.
The dietary approaches to stop hypertension (DASH) eating plan lowers BP, especially when combined with low salt intake. 14 Furthermore , we reported that DASH improves antioxidant capacity and reduces oxidative stress in metabolic syndrome patients with elevated BP. 15 It is not known whether low-sodium (LS)-DASH, differentially affects markers of oxidative stress and vascular function in SS and SR subjects compared to the original DASH eating plan, which is already high in antioxidants and flavonoids. In our study, therefore, we investigated the effect of DASH and LS-DASH on markers of oxidative stress and vascular function in SS and SR volunteers.
Methods
The study protocol was approved by the Office of Research Protection and Integrity at Medical University of South Carolina (MUSC). Volunteers were recruited from the staff and clinics at MUSC and paid. Written informed consent was obtained from all volunteers before the initial screening examination.
Subjects in this report were part of a previous DASH study. 16 The original study was designed to better delineate mechanisms by which DASH lowers BP. Two groups of subjects were recruited and included lean normotensive subjects without metabolic syndrome and obese hypertensive subjects with the metabolic syndrome. 17 Lean normotensive volunteers were 21-49 years of age and had body mass index (BMI) o25 kg/m 2 , waist circumference o102 cm for men and o88 cm for women, BP consistently o130/85 mm Hg on all three visits before the first study, fasting glucose o100 mg per 100 ml, fasting triglycerides o125 mg per 100 ml, high-density lipoprotein (HDL)-cholesterol 440 mg per 100 ml for men and 450 mg per 100 ml for women and/or total cholesterol/HDL o3.5. Obese hypertensive subjects were also 21-49 years old, had BP in the 130-159/85-99 mm Hg range on the three screening visits, BMI 427 kg/m 2 and waist circumference X40 inches for men and X35 inches for women. They also had at least one other risk factor including impaired fasting glucose (100-125 mg per 100 ml), fasting triglycerides 4150 mg per 100 ml or HDL-cholesterol o50 mg per 100 ml for women and o40 mg per 100 ml for men. 17 Subjects were excluded for diabetes mellitus (fasting glucose X126 mg per 100 ml or history of or treatment for diabetes), clinically evident target organ damage (4grade 2 Keith-Wagener change, left ventricular hypertrophy by electrocardiography, serum creatinine 41.5 mg per 100 ml) or history of stroke, transient ischaemic attack, myocardial infarction, angina pectoris or chronic heart failure.
Volunteers discontinued all non-essential prescription and non-prescription medications and supplements at least 3 weeks before the baseline dietary intervention. Volunteers who required medications to maintain a BP o160/o100 mm Hg were ineligible for the study. Medications that were allowed included antihistamines for allergies, H2receptor blockers and proton pump inhibitors for gastroesophageal reflux, and selective serotonin reuptake inhibitors for depression. Acetaminophen was allowed, whereas non-steroidal anti-inflammatory medications were not.
Study diets
Subjects followed four different diets for 3 weeks each. The first phase was a standardized usual low fruits and vegetables diet (ULFV) averaging one fruit and one vegetable, B1700 mg potassium, 250 mg magnesium and 11 grams of fibre daily. Subjects were randomized to the usual diet supplemented with potassium, magnesium and fibre (ULFV-S) to match DASH, or DASH itself. Subjects then completed the complementary phase of the randomized diet for 3 weeks. Salt intake across the first three diets was B3000 mg per day. After finishing the first three diets, subjects consumed a LS-DASH diet with target salt intake of 1500 mg per day. Of 30 volunteers completing the first three dietary periods, 19 also finished LS-DASH and are included in this report. All dietary phases were designed to maintain consistent intake of calcium, caffeine and alcohol. DASH without additional low-fat dairy was selected, because it was difficult to increase consumption of these items in our earlier study of freeliving volunteers.
To encourage dietary compliance, subjects met weekly with the General Clinical Research Center (GCRC) dietician. Sample menus of the standardized usual, DASH and LS-DASH diets were provided to each volunteer. Subjects were given a small digital camera (PenCam Vr; Aiptek, Irvine, CA, USA) to photograph all food intakes for 3 days before each weekly visit. Subjects were instructed to keep a food dairy for the same 3 days as well. A plastic ruler was given to the subjects to be placed in the picture field to facilitate more precise estimates of intake. To verify adherence with the study diets, subjects collected weekly 24-h urines for measurement of sodium and potassium. Nutrient consumption and dietary compliance were monitored closely by the GCRC dietician from 3-day food records and photographs as well as the urine data. Each subject's isocaloric energy intake was estimated using the Harris-Benedict equation, 18 and calories were adjusted each week according to clinic weights to minimize weight changes.
The macronutrient targets for the three diets were B50% carbohydrate, 35% fat and 15% protein. Target Na þ intake was 3000 mg daily for the ULFV and DASH diets and 1500 mg for LS-DASH. Calcium intake was B700 mg daily for all the diets. The Minnesota Nutrition Data Systems 19 (Nutrition Coordinating Center, Minneapolis, MN, USA) was used to analyse food records and pictures and estimate intake of multiple nutrients for each volunteer.
Haemodynamic measurements BP and heart rate were measured in triplicate with subjects seated quietly for the three qualifying visits and weekly thereafter for the remainder of the study. BP was measured by a trained observer using a mercury sphygmomanometer and appropriately sized cuff. Systolic BP was defined by the first Korotkoff sound, diastolic BP by the disappearance of the last (fifth) Korotkoff sound. Heart rate was measured by palpating the radial pulse for 60 s between the second and third BP measurements.
HDI/Pulse Wave CR-2000 (Eagan, MN, USA) 20 was used to estimate small and larger artery elasticity. 21 Central (aortic) BP were estimated using the Sphygmacor device (SCOR-MX, West Ryde, NSW, Australia). 22 Aortic augmentation index (AIx), a measure of vascular stiffness, was calculated. 22 Cardiac output, thoracic fluid content and heart rate were measured by BioZ impedance cardiography (Cardio-Dynamics, San Diego, CA, USA). 23 Metabolic assay methods Plasma insulin was measured by radioimmunoassay. 24 The homoeostatic model assessment of insulin resistance (HOMAir) was calculated. 25 Triglycerides, total and HDL-cholesterol were measured. 26 lowdensity lipoprotein (LDL)-cholesterol was calculated. 27 
F2-isoprostanes
Urine F2-isoprostanes were measured using gas chromotography/negative ion chemical ionization mass spectrometry by Dr Morrow as described in a previous collaboration. 21 Study design and protocol After following the ULFV diet for 3 weeks, subjects were randomized to either DASH or ULFV supplemented with potassium, magnesium and fibre to match DASH for 3 weeks and then 3 weeks on the alternative diet. After finishing the first three diets, subjects followed LS-DASH as the fourth 3-week dietary period.
Subjects were admitted to the GCRC at 0800 hours after 3 weeks on each diet and following an overnight fast. Intravenous access was obtained, and baseline haemodynamic data were recorded every 10 min for 1 h. Blood was drawn for the assays described.
Statistical analysis
Sample size estimates. Changes in isoprostanes represent a secondary study outcome. A sample size of nine per group affords 90% power to detect a within-group change of 20±15% at Pp0.05 and 75% power to detect a within-group change of 20 ± 20% using a two-sided, one-sample t-test. With two groups of nine each, the study had 70% power to detect differences of 40% between groups at Po0.05 using a two-sided, two-sample t-test.
As the supplemented diet (ULFV-S) did not affect BP in the previous report, that phase was excluded from the present analysis. 16 Group comparisons for descriptive categorical variables, for example, gender, were made using w 2 -tests. For descriptive continuous variables such as age, nutrient intake and BP, two sample t-tests were used for betweengroup comparisons. Changes in BP, other haemodynamic variables and selected biochemical measurements across the three dietary phases within and between groups were made using general linear models for repeated measures. All statistical analyses were performed with SAS Version 9.1. All statistical tests were two-sided, and P values o0.05 were accepted as significant.
Results

Baseline characteristics
Nineteen volunteers completed the study. Salt sensitivity was defined by systolic BP on LS-DASH X5 mm Hg below values on DASH. By this definition, 9 subjects were SS and 10 SR. Baseline characteristics of the two groups are provided in Table 1 including estimated glomerular filtration rates. 28 SS subjects were older than SR volunteers, and their BMI and estimated glomerular filtration rates lower, although the latter two were not statistically significantly. The two groups were otherwise similar including baseline BP.
Nutritional variables
Intake of fruits and vegetables on ULFV averaged B2 per day in contrast to B8 per day on DASH and LS-DASH ( Table 2 ). Sodium intake on LS-DASH was less than DASH and ULFV. Potassium, fibre and magnesium intakes were higher on DASH and LS-DASH than ULFV. Calcium and alcohol intake were comparable across the three diets.
Blood pressure
In SS subjects, systolic BP were lower on LS-DASH than on DASH and ULFV ( Figure 1 ). Systolic BP was lower on DASH than ULFV in SR subjects. SS subjects tended to have higher BMI at baseline and 
Nutrient differences between DASH and LS-DASH
Within-group differences between LS-DASH and DASH were generally minimal except for sodium intake (Table 3) . Between-group differences were also generally minimal as shown. 
Urine electrolytes
Urine Na þ was less on LS-DASH than DASH and ULFV in both groups. Urine potassium was higher on LS-DASH and DASH than the ULFV but not different between DASH and LS-DASH in both groups ( Table 4 ). Urine magnesium was higher on DASH than ULFV in all volunteers combined but not different from LS-DASH. Urine magnesium was not different on LS-DASH than ULFV in SS and SR groups separately.
Vascular function
AIx was lower in SS subjects on LS-DASH than DASH and ULFV (Figure 2 ). AIx was higher in SS than SR subjects on ULFV and DASH but not LS-DASH. AIx was lower on DASH than ULFV in SR subjects. Although estimated glomerular filtration rate (GFR) tended to be lower in SS than SR subjects ( Table 2) , AIx was not related to estimated GFR on any of the three study diets or to differences in AIx between the dietary periods (all r values o0. 36 , P values 40.1).
In SS subjects, small artery elasticity index was higher on LS-DASH than ULFV but not different from DASH. Large artery elasticity index generally followed the same pattern, but differences were not significant. Total systemic resistance (TSR) was marginally lower in SS subjects on LS-DASH than ULFV (P ¼ 0.06), but not DASH. No differences in small or large artery elasticity or TSR were observed in SR subjects among the study diets.
Cardiac output, thoracic fluid content and heart rate response to dietary intervention Thoracic fluid content and cardiac output were lower in SS subjects on LS-DASH than ULFV but Low-sodium DASH and oxidative stress Y Al-Solaiman et al were not different from DASH (Table 4 ). Heart rate in SS subjects was lower on LS-DASH than DASH or ULFV. These values were not different among study diets in SR subjects.
Urine F2-isoprostanes
In SS subjects, urine F2-isoprostanes were lower on LS-DASH than ULFV but were not significantly lower than DASH (Figure 3 ). Urine isoprostanes were not different in SR subjects among the three diets. Estimated glomerular filtration rate was marginally related to the change in urine F2isoprostanes between ULFV and DASH (r ¼ 0.44, P ¼ 0.06).
Plasma renin activity and plasma aldosterone concentration
Plasma renin activity was higher in SS volunteers on LS-DASH than ULFV (Table 4 ). Plasma aldosterone was higher on LS-DASH than ULFV in both groups and higher on LS-DASH than DASH in SR but not SS volunteers. 
Changes in insulin, HOMA index and lipid profile
Fasting insulin, HOMA and lipids were not different among the study diets in either SS or SR volunteers ( Table 4 ).
The study topic and key findings are summarized in Table 5 .
Discussion
In this study, salt sensitivity, defined by a reduction in systolic BP of 5 mm Hg or more on LS-DASH as compared to DASH was observed in 9 of 19 subjects. Among the SS subjects only, urine F2-isoprostanes, a marker of oxidative stress, declined during LS-DASH. Furthermore, the reduction of oxidative stress in SS subjects was associated with improvement in two indices of vascular function, namely, small artery elasticity increased and AIx decreased.
The mechanisms underlying these novel observations in SS humans are not known, but previous studies provide clues. Reactive oxygen species contribute to impaired endothelial function in SS rats 12, 29, 30 and decreased endothelium-dependent dilation in normotensive rats on high-salt diets. 31 One suggested mechanism is a decrease in nitric oxide synthase activity. 32, 33 Another possibility is that high-salt diets increase superoxide production, which interacts with nitric oxide to form peroxynitrite, thereby, reducing available nitric oxide. [34] [35] [36] In fact, salt loading in animal models of SS hypertension raises BP and decreases nitric oxide by increasing oxidative stress. 33 Decreased bioavailability of nitric oxide is implicated in the pathogenesis of human hypertension. 37, 38 In humans with SS hypertension, salt loading was associated with decreased plasma and urinary levels of nitric oxide metabolites. 8, 39 AIx appears to be a more sensitive marker of changes in arterial stiffness than pulse wave velocity among individuals less than 50 years of age, 40 which would include our volunteers. AIx correlates with both Framingham coronary heart disease risk 41 and endothelial function. 40 In this study, SS subjects had values for Aix, which were double those in SR volunteers, a difference that is probably not explained by age alone. 40 The improvement of arterial stiffness in SS subjects on LS-DASH was associated with reduction of BP and oxidative stress, which raises the possibility that salt sensitivity, oxidative stress and arterial stiffness are interrelated. LS-DASH also improved small artery elasticity, another marker of endothelial function, 42, 43 which likely contributed to the decline in AIx. In other words, rapid reflection of pressure waves from small arteries contribute to the second component of pulse-pressure, which is captured in AIx. 22, 44 Moreover, small artery elasticity is reduced in otherwise healthy individuals at risk for atherosclerosis. 45, 46 Heart rate declined significantly in SS subjects on LS-DASH, and, to a lesser degree in SR volunteers. This observation may reflect greater sympathetic activity on ULFV and DASH than LS-DASH. Previous studies also suggest greater sympathetic activity on higher than lower sodium intake in SS subjects. [47] [48] [49] Furthermore, SS hypertension is associated with alterations in autonomic cardiovascular control. 50, 51 In fact, impaired sympathetic inhibition has been described during high sodium intake in SS hypertensive humans, 2 and a defect in reflex cardiovascular control was proposed as a potential mechanism. 48 Thoracic fluid content decreased on LS-DASH in our SS subjects. The literature raises two possible explanations. First, as noted, evidence suggests that sympathetic activity declines in SS subjects with sodium restriction. An increase in sympathetic activity is associated with redistribution of blood volume towards the cardiopulmonary space, 52 and reduced sympathetic activity could reverse this phenomenon. Secondly, the decline in oxidative stress may have reduced body fluid volume including thoracic fluid content. [53] [54] [55] Oxidative stress enhances activity of both the Na/K þ /2Cl À cotransporter and the luminal Na þ /H þ exchanger. [56] [57] [58] Moreover, the decreased availability of nitric oxide in SS subjects on high-salt diets, could raise the renal threshold for pressure natriuresis and secondarily increase fluid retention. [58] [59] [60] The decrease in oxidative stress among SS subjects on LS-DASH may have reversed these phenomena.
The limitations of this study include a comparatively small sample size with adequate power only to detect comparatively large changes. Although the definition of salt sensitivity has been used in other studies, it is, nonetheless arbitrary. The dietary periods were not randomized, and there were no washout periods between the various dietary phases. Yet, all subjects followed the same dietary Low-sodium DASH and oxidative stress Y Al-Solaiman et al sequence. When these subjects were divided based on differences in systolic BP between DASH and LS-DASH, differences in urine F2-isoprostanes and vascular function were seen. And, the findings are consistent with previous published studies in humans and animals. In summary, LS-DASH, compared to a standardized usual diet, reduced oxidative stress and improved vascular function in SS but not SR volunteers in this study. The data further suggest that LS-DASH reduced sympathetic activity and facilitated sodium-volume excretion in this group. Thus, LS-DASH emerges as a useful intervention for not only lowering BP but also reducing oxidative stress and improving vascular-endothelial function in SS subjects. Although DASH is also beneficial in SR subjects, additional benefits of LS-DASH were not observed within the limited time period encompassed by this study.
